Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. on April 4, 2018, reporting events occurring on April 3 and April 4, 2018. The filing details the closing of a previously announced firm commitment underwritten public offering.
Key Financial Metrics
The filing reports the following capital raise metrics:
- Gross Proceeds: Approximately $15.9 million after the full exercise of the underwriters' overallotment option.
- Initial Sale: 15,660,000 Common Units and 7,840,000 Pre-Funded Units sold at $0.65 and $0.64 per unit respectively, generating approximately $15.2 million.
- Overallotment Exercise: An additional 1,150,000 Common Units were sold on April 4, 2018.
- Net Proceeds: The filing does not provide a clear value for net proceeds after deducting underwriting discounts, commissions, and offering expenses.
- Operating Metrics: The filing does not provide data on revenue, profit, cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the significant increase in the company's cash position and share count resulting from the public offering. The filing does not provide comparative financial data against a prior period to quantify changes in operating performance.
Outlook, Risks, and Unusual Items
The filing does not contain management commentary on future guidance, specific risks, or contingencies beyond the standard disclosure of the offering structure. The transaction involved the issuance of Common Units (comprising common stock, Series A warrants, and Series B warrants) and Pre-Funded Units (comprising pre-funded warrants, Series A warrants, and Series B warrants).
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and offering expenses.
- Review the terms and exercise prices of the Series A and Series B warrants issued in the offering.
- Confirm the updated total share count and potential dilution impact on existing shareholders.
- Check the March 28, 2018 Form 8-K referenced in the text for detailed offering terms.